Atlas Trials

Effect of 0.5% vs 0.375% Ropivacaine on Autonomous Nervous System

Clinical trial NCT02125994 · UNKNOWN

Trial details

NCT number
NCT02125994
Sponsor
Larissa University Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Shoulder SurgeryInterscalene Nerve BlockRopivacaine
Start date
2014-03-01
Primary completion
2015-10-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.